Editorial
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Dec 26, 2024; 12(36): 6871-6876
Published online Dec 26, 2024. doi: 10.12998/wjcc.v12.i36.6871
Advances in the management of arteriosclerosis of the lower extremity: Integrating Western and Chinese medicine approaches
Sha Cheng, Jia-Xin Xu, Wen-Jie Long
Sha Cheng, Jia-Xin Xu, Department of Cardiovascular, The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University, Guangzhou 510000, Guangdong Province, China
Wen-Jie Long, Department of Geriatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510006, Guangdong Province, China
Co-first authors: Sha Cheng and Jia-Xin Xu.
Author contributions: Cheng S collected domestic and foreign literature, wrote the manuscript, conceived the structure of the article, organized the language of the article, clearly conveyed the author's point of view, and reflected on the depth and persuasiveness of the article; Xu JX made revisions and improvements to the article, including language polish, logical adjustments, and data updates; Long WJ was responsible for cutting-edge trends, selecting review topics , research hotspots, ensuring the article is innovative and timely, and conduct a final review of the article; all of the authors read and approved the final version of the manuscript to be published.
Supported by The Scientific Research Project of Guangdong Provincial Bureau of Traditional Chinese Medicine, China, No. 2022ZYYJ01; and The Guangzhou Municipal Science and Technology Bureau's 2024 Basic and Applied Basic Research Topic, China, No. 2024A04J4254.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Wen-Jie Long, MD, PhD, Attending Doctor, Department of Geriatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, No. 16 Jichang Road, Guangzhou 510006, Guangdong Province, China. derek1626@163.com
Received: July 19, 2024
Revised: August 29, 2024
Accepted: September 25, 2024
Published online: December 26, 2024
Processing time: 103 Days and 16.3 Hours
Core Tip

Core Tip: Lower extremity arteriosclerosis obliterans (LEASO), a condition primarily influenced by smoking and diabetes, significantly increases the risks of limb ischemia and amputation. Current treatments, such as pharmacological and surgical interventions, provide limited relief. Integrative approaches that combine traditional Chinese medicine with Western medical practices offer holistic and personalized treatment strategy that focuses on addressing the root cause as well as managing symptoms. To establish the efficacy and safety of this combined approach, extensive randomized controlled trials are essential. Such evidence-based research is crucial for developing protocols that can improve patient outcomes in managing LEASO.